Diagnostic Products Corp.

Immunodiagnostics company receives subpoena

Published in Physician Law Weekly, September 8th, 2004

Diagnostic Products Corp. (DP) (DPC) announced that it has received a subpoena from the United States Attorney's Office to produce to a Federal Grand Jury documents relating to trading in the company's stock by employees, officers, and directors in early 2004 as well as documents related to the FDA's (U.S. Food and Drug Administration) review of the company's application for a test to detect Chagas disease.

The company has been in communication, and is cooperating with the United States Securities and Exchange Commission (SEC) regarding these matters.

An independent committee of its board of directors initiated and conducted an investigation of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2004-09-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry